BRIEF published on 09/25/2024 at 15:05, 1 year 5 months ago GEN Reports Positive Phase 2 Trial Results for GN-037 Topical Cream Clinical Efficacy Phase 2 Trial Results GN-037 Topical Cream Plaque Psoriasis Treatment GEN Pharmaceuticals
PRESS RELEASE published on 09/25/2024 at 15:00, 1 year 5 months ago GEN Announces Positive Phase 2 Clinical Trial Results for GN-037 Topical Cream in Patients With Mild to Moderate Plaque Psoriasis GEN Pharmaceuticals announces positive Phase 2 trial results for GN-037 topical cream in treating plaque psoriasis, presented at EADV Congress 2024 Phase 2 Trial GN-037 Topical Cream GEN Pharmaceuticals Plaque Psoriasis EADV Congress
Published on 03/05/2026 at 20:00, 2 hours 34 minutes ago PPX Hosts Medical Outreach Campaign for Local Communities
Published on 03/05/2026 at 17:55, 4 hours 39 minutes ago ACCESS Newswire to Host Fourth Quarter and Year End Earnings Conference Call on March 19, 2026
Published on 03/05/2026 at 14:00, 8 hours 34 minutes ago EQ Inc. Secures Strategic Partnership with Global Card Network to Expand Integrated Rewards Across Canada
Published on 03/05/2026 at 14:00, 8 hours 34 minutes ago GameSquare's Stream Hatchet Publishes 2025 YouTube Gaming Trends Report
Published on 03/05/2026 at 14:00, 8 hours 34 minutes ago Horizon Aircraft's Unique VTOL Delivers Up to 75% Lower Operating Costs Than Helicopters
Published on 03/05/2026 at 19:49, 2 hours 45 minutes ago EQS-Adhoc: Northern Data Announces Preliminary Q4 2025 revenue and FY 2026 outlook
Published on 03/05/2026 at 19:15, 3 hours 19 minutes ago Huawei Wins Eight GLOMO Awards at MWC Barcelona 2026
Published on 03/05/2026 at 19:05, 3 hours 29 minutes ago Supercharging Edge AI: Apacer Launches Industrial Grade Storage for Raspberry Pi Platforms
Published on 03/05/2026 at 18:40, 3 hours 54 minutes ago 2025 Full-year results FREY: a pan-European platform already creating value
Published on 03/05/2026 at 18:34, 4 hours ago Mersen: Number of shares and voting rights as of February 28, 2026
